Maureen Bennett represents life sciences and health care clients conducting global clinical trials and research collaborations. For almost 20 years, Maureen has advised clients on the contractual, regulatory, and ethical issues associated with clinical research. She negotiates clinical trial agreements, reviews informed consents, provides advice regarding novel patient recruitment strategies, and assists with interactions with regulatory agencies, including the U.S. Food & Drug Administration (FDA).
She has advised health care systems and life sciences companies regarding the conduct of global trials for therapeutics and vaccines to address COVID-19.
Maureen advises clients on emerging regulatory issues affecting clinical research, including the utilization of social media in patient and physician recruitment, the development of virtual clinical trial and telemedicine networks, and personalized medicine strategies implementing the use of biomarkers and companion diagnostics.
Maureen also represents clients in the structuring of complex outsourcing arrangements between life sciences companies and contract research organizations (CROs). She has advised entities in the establishment of compliant decentralized clinical trials.
She also represents clients in the assessment and mitigation of regulatory risks and the negotiation of liability allocation arrangements in M&A, licensing, and other commercial transactions.
Maureen is the life sciences co-leader for the Firm's Health Care & Life Sciences Practice and formerly served as co-chair of the Boston Bar Association's Health Care Section. She was honorary co-chair for the 8th Annual Boston-Northwest Ireland Golden Bridges Giant Step Conference 2020 and is a regular speaker at industry conferences. Maureen is co-chair of the Firm's LGBTQ affinity group.
